Another novel research chemical from the group of dopaminergic stimulants has been added to our product portfolio, and it has instantly been recognized as one of the most intriguing agents. In terms of molecular structure, Nitracaine looks very alike to dimethocaine, a related analogue of cocaine that has been the subject of research activity in the recent period. The substance acts as a local anaesthetic, while also showing a pronounced ability to affect the dopamine binding mechanism by blocking reuptake of neurotransmitter molecules. Very little is known about possible chemical interactions of Nitracaine beyond this, and it is necessary to conduct multiple peer-reviewed studies before this chemical can be adequately explained and classified.

Another novel research chemical from the group of dopaminergic stimulants has been added to our product portfolio, and it has instantly been recognized as one of the most intriguing agents. In terms of molecular structure, Nitracaine looks very alike to dimethocaine, a related analogue of cocaine that has been the subject of research activity in the recent period. The substance acts as a local anaesthetic, while also showing a pronounced ability to affect the dopamine binding mechanism by blocking reuptake of neurotransmitter molecules. Very little is known about possible chemical interactions of Nitracaine beyond this, and it is necessary to conduct multiple peer-reviewed studies before this chemical can be adequately explained and classified.